Amanote Research
Register
Sign In
Lp-Pla2 Inhibition—The Atherosclerosis Panacea?
Pharmaceuticals
- Switzerland
doi 10.3390/ph3051360
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Pharmaceutical Science
Date
April 29, 2010
Authors
Mahir Karakas
Wolfgang Koenig
Publisher
MDPI AG
Related search
Serum Lp-Pla2: As a Novel Viewpoint in Periodontal Treatment of Hyperlipidaemics
Turkish Journal of Medical Sciences
Medicine
Lp-Pla2 Activity and Mass and CRP Are Associated With Incident Symptomatic Peripheral Arterial Disease
Scientific Reports
Multidisciplinary
Associação Da Atividade De Lp-Pla2 E De Antioxidantes Lipossolúveis Com Marcadores Cardiometabólicos Em Adolescentes
Lipoprotein-Associated Phospholipase A2(Lp-Pla2) as a Therapeutic Target to Prevent Retinal Vasopermeability During Diabetes
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Relationship Between Lp (A) and Arteriographic Feature of Coronary Atherosclerosis
The Journal of Japan Atherosclerosis Society
In Silico and in Vitro Study of the Bromelain-Phytochemical Complex Inhibition of Phospholipase A2 (Pla2)
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Effect of Cardiovascular Drugs on the Plasma Levels of Lipoprotein- Associated Phospholipase A2 (Lp-Pla2)~!2009-10-29~!2009-12-28~!2010-04-08~!
The Open Clinical Chemistry Journal
The Inhibition of Coronary Atherosclerosis by Estrogens in Cholesterol-Fed Chicks
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Statins; The Panacea of Cardiovascular Disease
Netherlands Heart Journal
Cardiovascular Medicine
Cardiology
